Cocrystal Pharma COCP
NASDAQ COCP
$1.17 +0.02 (+2.18%)
At close: Aug 20, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) FCF Margin (2010 - 2026)

Cocrystal Pharma (COCP) posted FCF Margin of 1040.0% for Q1 2026, down 122.67% sequentially from 467.06% in Q4 2020.

Cocrystal Pharma (COCP) FCF Margin (2010 - 2026) Analysis & Trends

Cocrystal Pharma has reported FCF Margin for 7 years, with the latest figure at 1040.0% in Q1 2026.

  • Quarterly FCF Margin changed N/A year-over-year to 1040.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 427.5% (changed N/A YoY) and the FY2020 annual result came in at 500.0%, down 47398.0% from the prior year.
  • FCF Margin fell to 1040.0% in Q1 2026 per COCP's latest filing, from 467.06% in the prior quarter.
  • Over five years, FCF Margin peaked at 1040.0% in Q1 2026 and troughed at 1040.0% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 30.39%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 13.35%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -388.28%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 25.68%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 22.62%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -22.35%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 70.82%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 41.07%
10 Cocrystal Pharma 15.86 Mn 13.54 Mn - -2,396.19%

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,396.19%
Mar 31, 2026 -1,040.00%
Dec 31, 2020 -467.06%
Sep 30, 2020 -629.86%
Jun 30, 2020 -420.04%
Mar 31, 2020 -494.79%
Dec 31, 2019 -306.22%
Sep 30, 2019 -292.28%
Jun 30, 2019 -174.32%
Mar 31, 2019 39.25%
Jun 30, 2013 -34.90%
Mar 31, 2013 2.71%
Dec 31, 2012 5.57%
Sep 30, 2012 7.33%
Jun 30, 2012 -2.80%
Mar 31, 2012 -62.05%
Dec 31, 2011 -21.76%
Sep 30, 2011 16.82%
Jun 30, 2011 -14.49%
Mar 31, 2011 -17.41%